Cell-specific metabolism and pathogenesis of transmembrane prion protein

Molecular and Cellular Biology

Volumn 26, Issue 7, 2006, Pages 2697-2715

  Gu, Yaping ^a   Luo, Xiu ^a   Basu, Subhabrata ^a   Fujioka, Hisashi ^a   Singh, Neena ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIVISION; CELL METABOLISM; CELL SHAPE; CELL SIZE; CONTROLLED STUDY; CYTOKINESIS; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; MOUSE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; REGULATORY MECHANISM; RISK FACTOR;

ANIMALS; CELL MEMBRANE; CHO CELLS; CRICETINAE; CRICETULUS; CYTOKINESIS; ENDOPLASMIC RETICULUM; EPITOPES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; PRIONS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RECOMBINANT PROTEINS;

ANIMALIA;

EID: 33645239807     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.26.7.2697-2715.2006     Document Type: Article

References (35)

1. Aguzzi, A., and M. Polymenidou. 2004. Mammalian prion biology: one century of evolving concepts. Cell 116:313-327.
2. Becker, E. B., and A. Bonni. 2004. Cell cycle regulation of neuronal apoptosis in development and disease. Prog. Neurobiol. 72:1-25.
3. Brown, M. S., and J. L. Goldstein. 1997. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331-340.
4. Chabry, J., C. Ratsimanohatra, I. Sponne, P. P. Elena, J. P. Vincent, and T. Pillot. 2003. In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression. J. Neurosci. 23:462-469.
5. Chen, Y., W. Liu, D. L. McPhie, L. Hassinger, and R. L. Neve. 2003. APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer's disease brain. J. Cell Biol. 163:27-33.
6. Chen, S. G., D. B. Teplow, P. Parchi, J. K. Teller, P. Gambetti, and L. Autilio-Gambetti. 1995. Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem. 270:19173-19180.
7. Conn, C. W., R. F. Hennigan, W. Dai, Y. Sanchez, and P. J. Stambrook. 2000. Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian Polo-like kinase, Plk3. Cancer Res. 60:6826-6831.
8. Dimcheff, D. E., J. L. Portis, and B. Caughey. 2003. Prion proteins meet protein quality control. Trends Cell Biol. 13:337-340.
9. Gabus, C., S. Auxilien, C. Pechoux, D. Dormont, W. Swietnicki, M. Morillas. W. Surewicz, P. Nandi, and J. L. Darlix. 2001. The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. J. Mol. Biol. 307:1011-1021.
10. Garcia, P. D., J. H. Ou, W. J. Rutter, and P. Walter. 1988. Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm. J. Cell Biol. 106:1093-1104.
11. Gromley, A., A. Jurczyk, J. Sillibourne, E. Balilovic, M. Mogensen, I. Groisman, M. Blomberg, and S. Doxsey. 2003. A novel human protein of the maternal centriole is required for the final stages of cytokinesis and entry into S phase. J. Cell Biol. 161:535-545.
12. Gu, Y., H. Fujioka, R. S. Mishra, R. Li, and N. Singh. 2002. Prion peptide 106-126 modulates the aggregation of cellular prion protein and induces the synthesis of potentially neurotoxic transmembrane PrP. J. Biol. Chem. 277:2275-2286.
13. Gu, Y., S. Verghese, R. S. Mishra, X. Xu, Y. Shi, and N. Singh. 2003. Mutant prion protein-mediated aggregation of normal prion protein in the endoplasmic reticulum: implications for prion propagation and neurotoxicity. J. Neurochem. 84:10-22.
14. Gu, Y., J. Hinnerwisch, R. Fredricks, S. Kalepu, R. S. Mishra, and N. Singh. 2003. Identification of cryptic nuclear localization signals in the prion protein. Neurobiol. Dis. 12:133-149.
15. Haze, K., H. Yoshida, H. Yanagi, T. Yura, and K. Mori. 1999. Mammalian transcription factor ATF is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol. Biol. Cell 10:3787-3799.
16. Hegde, R. S., J. A. Mastrianni, M. R. Scott, K. A. DeFea, P. Tremblay, M. Torchia, S. J. DeArmond, S. B. Prusiner, and V. R. Lingappa. 1998. Transmembrane form of the prion protein in neurodegenerative disease. Science 279:827-834.
17. Hegde, R. S., S. Voigt, and V. R. Lingappa. 1998. Regulation of protein topology by trans-acting factors at the endoplasmic reticulum. Mol. Cell 2:85-91.
18. Hegde, R. S., P. Tremblay, D. Groth, S. J. DeArmond, S. B. Prusiner, and V. R. Lingappa. 1999. Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402:822-826.
19. Heller, U., K. F. Winklhofer, J. Heske, A. Reintjes, and J. Tatzelt. 2003. Post-translational import of the prion protein into the endoplasmic reticulum interferes with cell viability: a critical role for the putative transmembrane domain. J. Biol. Chem. 278:36139-36147.
20. Holscher, C., U. C. Bach, and B. Dobberstein. 2001. Prion protein contains a second endoplasmic reticulum targeting signal sequence located at its C terminus. J. Biol. Chem. 276:13388-13394.
21. Kim, S. J., D. Mitra, J. R. Salerno, and R. S. Hegde. 2002. Signal sequences control gating of the protein translocation channel in a substrate-specific manner. Dev. Cell 2:207-217.
22. Kim, S. J., R. Rahbar, and R. S. Hegde. 2001. Combinatorial control of prion protein biogenesis by the signal sequence and transmembrane domain. J. Biol. Chem. 276:26132-26140.
23. Low, S. H., X. Li, M. Miura, N. Kudo, B. Quinones, and T. Weimbs. 2003. Syntaxin 2 and endobrevin are required for the terminal step of cytokinesis in mammalian cells. Dev. Cell 4:753-759.
24. Ma, J., R. Wollmann, and S. Lindquist. 2002. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298:1781-1785.
25. Mange, A., C. Crozet, S. Lehmann, and F. Beranger. 2004. Scrapie-like prion protein is translocated to the nuclei of infected cells independently of proteasome inhibition and interacts with chromatin. J. Cell Sci. 117:2411-2416.
26. Martoglio, B., and B. Dobberstein. 1998. Signal sequences: more than just greasy peptides. Trends Cell Biol. 8:410-415.
27. Ooi, C. E., and J. Weiss. 1992. Bidirectional movement of a nascent polypeptide across microsomal membranes reveals requirements for vectorial translocation of proteins. Cell 71:87-96.
28. Ott, C. M., and V. R. Lingappa. 2004. Signal sequences influence membrane integration of the prion protein. Biochemistry 43:11973-11982.
29. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. USA 95:13363-13383.
30. Rane, N. S., J. Yonkovich, and R. S. Hegde. 2004. Protection from cytosolic prion protein toxicity by modulation of prion translocation. EMBO J. 23:4550-4559.
31. Stewart, R. S., B. Drisaldi, and D. A. Harris. 2001. A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic reticulum. Mol. Biol. Cell 12:881-889.
32. Stewart, R. S., and D. A. Harris. 2003. Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection. J. Biol. Chem. 278:45960-45968.
33. Stewart, R. S., P. Piccardo, B. Ghetti, and D. A. Harris. 2005. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein. J. Neurosci. 25:3469-3477.
34. Stewart, R. S., and D. A. Harris. 2005. A transmembrane form of the prion protein is localized in the Golgi apparatus of neurons. J. Biol. Chem. 280:15855-15864.
35. Tomas, A., C. Futter, and S. E. Moss. 2004. Annexin 11 is required for midbody formation and completion of the terminal phase of cytokinesis. J. Cell Biol. 165:813-822.